3513 Brighton Boulevard
Suite 410
Denver, CO 80216
United States
844 427 8100
https://www.seastarmedical.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 12
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Eric Schlorff | CEO, President & Executive Director | 420k | N/A | 1973 |
Colonel Kevin Chung FACP, M.D. | Chief Medical Officer | 350k | N/A | 1973 |
Dr. H. David Humes M.D. | Co-Founder and Managing Director | 135.71k | N/A | N/A |
Mr. David A. Green CPA, M.B.A. | Chief Financial Officer | N/A | N/A | 1963 |
Tom Mullen | Vice President of Operations & Product Development | N/A | N/A | N/A |
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.